Stockscreener 앱 받기
4.17
2.57%
-0.11
시간 외 거래:
4.17
전일 마감가:
$4.28
열려 있는:
$4.29
하루 거래량:
573.29K
Relative Volume:
0.82
시가총액:
$534.17M
수익:
$193.01M
순이익/손실:
$-12.15M
주가수익비율:
-46.33
EPS:
-0.09
순현금흐름:
$454.00K
1주 성능:
-6.71%
1개월 성능:
-19.81%
6개월 성능:
-12.03%
1년 성능:
-39.21%
1일 변동 폭
$4.16
$4.29
1주일 범위
$4.16
$4.61
52주 변동 폭
$4.16
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
명칭
Cytek Biosciences Inc
전화
(877) 922-9835
주소
47215 LAKEVIEW BOULEVARD, FREMONT
CTKB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.17 | 534.17M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-31 | 다운그레이드 | Goldman | Buy → Sell |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
Cytek Biosciences Inc 주식(CTKB)의 최신 뉴스
Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges - Investing.com India
Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript - MSN
Cytek Biosciences (CTKB) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Principal Financial Group Inc. - Defense World
Cytek Biosciences (NASDAQ:CTKB) Price Target Cut to $8.00 by Analysts at Piper Sandler - Defense World
Cytek Biosciences Reports Mixed Earnings Amid Growth and Challenges - TipRanks
Cytek Biosciences (NASDAQ:CTKB) Hits New 1-Year Low – Here’s Why - Defense World
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges - Investing.com Australia
Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation? - Yahoo Finance
Cytek Biosciences (NASDAQ:CTKB) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges By Investing.com - Investing.com South Africa
Cytek Biosciences, Inc. SEC 10-K Report - TradingView
Cytek Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cytek Biosciences Reports Growth and Strategic Expansion - TipRanks
Cytek Biosciences earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Cytek Biosciences Q4 2024 results miss forecasts By Investing.com - Investing.com South Africa
Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates - Yahoo Finance
Earnings call transcript: Cytek Biosciences Q4 2024 results miss forecasts - Investing.com
Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M - TipRanks
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook - GlobeNewswire
Cytek's Earnings Show Profitability Surge: Net Loss Halved While Revenue Climbs Just 4% - StockTitan
Cytek Biosciences (CTKB) to Release Quarterly Earnings on Thursday - MarketBeat
(CTKB) Proactive Strategies - Stock Traders Daily
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Update - MarketBeat
Cytek Biosciences (CTKB) Projected to Post Quarterly Earnings on Thursday - Defense World
Cytek Biosciences (NASDAQ:CTKB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Prenetics Global (NASDAQ:PRE) and Cytek Biosciences (NASDAQ:CTKB) Head to Head Analysis - Defense World
Cytek Biosciences to Announce Q4 and Full Year 2024 Financial Results on February 27, 2025 - Nasdaq
Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire
Cytek Biosciences Earnings Alert: Key Q4 and Full Year 2024 Results Coming February 27 - StockTitan
Cytek Biosciences, Inc. (NASDAQ:CTKB) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Cytek Biosciences (NASDAQ:CTKB) Sees Unusually-High Trading Volume – Here’s What Happened - Defense World
Keeping an Eye on Cytek BioSciences Inc (CTKB) After Insider Trading Activity - Knox Daily
Cytek Biosciences (NASDAQ:CTKB) Trading Down 4%Should You Sell? - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Shares Up 5%What's Next? - MarketBeat
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Strategic Investor Access: Cytek Sets Ambitious 4-Conference Roadshow for Early 2025 - StockTitan
Pacer Advisors Inc. Buys Shares of 30,155 Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Down 4% – Should You Sell? - Armenian Reporter
Market Insights: Cytek BioSciences Inc (CTKB)’s Notable Gain of 4.66, Closing at 5.39 - The Dwinnex
Cytek Biosciences (NASDAQ:CTKB) Shares Gap DownHere's Why - MarketBeat
Cytek Biosciences price target raised to $5.25 from $4.50 at Goldman Sachs - MSN
Cytek Biosciences (NASDAQ:CTKB) Cut to Sell at The Goldman Sachs Group - Defense World
Cytek Biosciences Inc (CTKB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.08%
0.71%
자본화:
|
볼륨(24시간):